Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication
IRCT2015030820178N2Phase 3Completed
- Sponsor
- Iran University of Medical Sciences,Rasoul Akram Hospital,Colorectal Research Center
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of levofloxacin and clarithromycin in Helicobacter pylori infection and Peptic ulcer disease (PUD) (2 arms), sponsored by Iran University of Medical Sciences,Rasoul Akram Hospital,Colorectal Research Center. Started Jan 2015; status: completed.
02
Drugs
levofloxacinclarithromycin
03
Conditions
Helicobacter pylori infectionPeptic ulcer disease (PUD)
Beyond the preview
Go deeper on IRCT2015030820178N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2015030820178N2.